Reduced expression of the tumor suppressor PHLPP1 enhances the antiapoptotic B-cell receptor signal in chronic lymphocytic leukemia B-cells
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reduced expression of the tumor suppressor PHLPP1 enhances the antiapoptotic B-cell receptor signal in chronic lymphocytic leukemia B-cells
Authors
Keywords
-
Journal
LEUKEMIA
Volume 24, Issue 12, Pages 2063-2071
Publisher
Springer Nature
Online
2010-09-23
DOI
10.1038/leu.2010.201
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impaired expression of p66Shc, a novel regulator of B-cell survival, in chronic lymphocytic leukemia
- (2010) N. Capitani et al. BLOOD
- Protein phosphatase PHLPP1 controls the light-induced resetting of the circadian clock
- (2010) S. Masubuchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia
- (2009) M. Herling et al. BLOOD
- Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach
- (2009) M. Niedermeier et al. BLOOD
- Akt inhibitors induce apoptosis in chronic lymphocytic leukemia cells
- (2009) M. de Frias et al. HAEMATOLOGICA
- Akt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: the therapeutic potential of Akt inhibition
- (2009) J. Zhuang et al. HAEMATOLOGICA
- Depletion of Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatases 1 and 2 by Bcr-Abl Promotes Chronic Myelogenous Leukemia Cell Proliferation through Continuous Phosphorylation of Akt Isoforms
- (2009) Isao Hirano et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Infrequent occurrence ofPIK3CAmutations in chronic lymphocytic leukemia
- (2009) Millaray Marincevic et al. LEUKEMIA & LYMPHOMA
- -TrCP-Mediated Ubiquitination and Degradation of PHLPP1 Are Negatively Regulated by Akt
- (2009) X. Li et al. MOLECULAR AND CELLULAR BIOLOGY
- c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches
- (2008) D. Y. H. Hallaert et al. BLOOD
- AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance
- (2008) K. Balakrishnan et al. BLOOD
- The transforming mutation E17K/AKT1 is not a major event in B-cell-derived lymphoid leukaemias
- (2008) I S Mahmoud et al. BRITISH JOURNAL OF CANCER
- Chronic lymphocytic leukaemia and acute myeloid leukaemia are not associated with AKT1 pleckstrin homology domain (E17K) mutations
- (2008) T. Zenz et al. BRITISH JOURNAL OF HAEMATOLOGY
- Integrated Genomic Profiling of Chronic Lymphocytic Leukemia Identifies Subtypes of Deletion 13q14
- (2008) P. Ouillette et al. CANCER RESEARCH
- Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation
- (2008) P. Ghia et al. JOURNAL OF INTERNAL MEDICINE
- Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia
- (2008) J B Weinberg et al. LEUKEMIA
- Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis
- (2008) J Liu et al. ONCOGENE
- PI3K pathway alterations in cancer: variations on a theme
- (2008) T L Yuan et al. ONCOGENE
- PHLiPPing the switch on Akt and protein kinase C signaling
- (2008) John Brognard et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started